Phase 3 Data For Nontuberculous Lung Disease Trial Has Been Published
<a href="https://pixabay.com/users/allinonemovie/">allinonemovie</a> / Pixabay

Phase 3 Data For Nontuberculous Lung Disease Trial Has Been Published

According to a story from pm360online.com, the biopharmaceutical company Insmed Incorporated recently announced that the data from its Phase 3 clinical trial of amikacin liposome inhalation suspension (ALIS). ALIS was…

Continue Reading
Close Menu